The PAM50 Risk-of-Recurrence Score Predicts Risk for Late Distant Recurrence after Endocrine Therapy in Postmenopausal Women with Endocrine-Responsive Early Breast Cancer
暂无分享,去创建一个
R. Greil | T. Nielsen | S. Ferree | C. Schaper | Shuzhen Liu | M. Gnant | P. Regitnig | Z. Bago-Horvath | P. Dubsky | R. Jakesz | C. Singer | M. Filipits | E. Müller-Holzner | J. Cowens | T. Bauernhofer | M. Knauer | C. Fesl | O. Dietze | M. Rudas | B. Mlineritsch | M. Hubalek | Christine Gruber-Rossipal | H. Trapl | H. Stöger